Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Clinical trial condition

Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma

Explore clinical trials studying Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma trial results

Recruiting

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

NCT06514898

Conditions: Glioma, Medulloblastoma, Neoplasms, +9 more
Locations: University of Florida Health Gainesville, Florida, United States

View Trial Details